上海
分享至
CRO概念午后快速拉升，截至发稿，美迪西、昭衍新药涨超8%，皓元医药涨超7%，康龙化成、药明康德涨超6%，泰格医药、博腾股份等大幅冲高。民生证券认为，市场逐步关注业绩高成长板块带来的投资机遇，CXO在医药行业各细分板块内，业绩高成长性和持续性仍然名列前茅。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
